Amanote Research
Register
Sign In
Synthesis of a PCSK9 Inhibitor
Synfacts
doi 10.1055/s-0037-1609112
Full Text
Open PDF
Abstract
Available in
full text
Date
February 15, 2018
Authors
Unknown
Publisher
Georg Thieme Verlag KG
Related search
Efficacy and Safety of the PCSK9 Inhibitor Evolocumab in Patients With Mixed Hyperlipidemia
Cardiovascular Drugs and Therapy
Medicine
Cardiovascular Medicine
Pharmacology
Cardiology
Synthesis of a Glycine Transporter 1 Inhibitor
Synfacts
Gingival Ischemia and Petechiae in a Patient Medicated With PCSK9 Inhibitor for Hypercholesterolemia. An Adverse Drug Event?
Clinical advances in periodontics
Periodontics
Does Evolocumab, as a PCSK9 Inhibitor, Ameliorate the Lipid Profile in Familial Hypercholesterolemia Patients? A Meta-Analysis of Randomized Controlled Trials
Journal of Pharmacy and Pharmaceutical Sciences
Medicine
Pharmacology
Pharmaceutical Science
Synthesis of SMO Inhibitor PF-04449913
Synfacts
Macarbomycin, an Inhibitor of Peptidoglycan Synthesis
Journal of Antibiotics
Drug Discovery
Pharmacology
A Therapeutic Peptide Vaccine Against PCSK9
Scientific Reports
Multidisciplinary
Terpentecin, an Inhibitor of DNA Synthesis.
Journal of Antibiotics
Drug Discovery
Pharmacology
Asymmetric Synthesis of the Aminocyclitol Pactamycin, a Universal Translocation Inhibitor
Journal of the American Chemical Society
Biochemistry
Colloid
Catalysis
Chemistry
Surface Chemistry